PsA-TT-007

计划入组 1,500 人

PsA-TT-006

计划入组 6,000 人

TT-4 and TT-10 as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors and Pleural Mesothelioma

计划入组 35 人 · 首次发布于 2021 年 7 月 20 日

TT-00920

TT-01488

TT-00973

Total Metals Corp

United States

MenACYW-TT Booster Shows Robust Immune Response Against Meningococcal Disease in Adolescents

Teitur Trophics' First-in-Class Peptide TT-P34 Clears Phase I in Parkinson's, Confirming Brain Exposure

Cyncado Therapeutics Presents First Evidence of A2B Receptor Inhibition's Direct Anti-Tumor Effects in Mesothelioma